XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Common Stock (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Aug. 14, 2023
May 03, 2023
Oct. 30, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of common stock converted           7,087
Issuance of Series E preferred stock, warrants and common stock, shares 670,499 3,860,917 400,667      
Issuance of Series E preferred stock, warrants and common stock       $ 19,834,407 $ 16,447,649  
Member Units [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of common stock converted   2,297,669        
Issuance of common stock and warrants in conjunction with purchase of Exok Option assets, shares   2,297,669        
Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of common stock converted   2,297,668        
Issuance of common stock and warrants in conjunction with purchase of Exok Option assets, shares   3,860,991   670,499 3,860,917  
Issuance of Series E preferred stock, warrants and common stock, shares   3,860,917 [1]   39,614   5,695,387
Issuance of Series E preferred stock, warrants and common stock   $ 9,928,262   $ 396  
Common Stock [Member] | Obligation Shares [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Issuance of Series E preferred stock, warrants and common stock, shares   205,970        
Issuance of Series E preferred stock, warrants and common stock   $ 1,477,103        
[1] For purposes of this unaudited pro forma combined financial information, 3,860,917 represents the historical shares of the Common Stock outstanding immediately prior to the closing of the Merger on May 3, 2023.